Virbac's Bold Move: Dominating Japan's Animal Health Industry with Sasaeah Acquisition

irbac, a major player in the global animal health industry, has made a bold move by acquiring Sasaeah, a subsidiary of ORIX Corporation, in a €280 million deal. Sasaeah, formed through the merger of two prominent animal health providers in Japan, boasts substantial revenue and a diverse portfolio of veterinary products. This acquisition positions Virbac as a leader in Japan's farm animal vaccines market and grants access to Sasaeah's manufacturing sites and skilled workforce. The deal, expected to close swiftly, underscores Virbac's commitment to expanding its presence in key markets and shaping the future of animal health in Japan and beyond.